And Albany Molecular Study, Inc. To stay the exceptional patent litigation regarding Barr’s generic edition of Aventis Pharmaceuticals’ Allegra D-12 Hour extended-release tablets. Beneath the terms of the agreement, Barr is definitely permitted to release a generic edition of Aventis Pharmaceuticals’ Allegra D-12 extended-launch tablets on November 1, 2009, and Barr gets the right to acquire item from Sanofi-Aventis for industrial launch. Upon product release, Barr would pay out Sanofi-Aventis a royalty. Allegra Tablets Settlement Contract Barr Laboratories, Inc. And Teva Pharmaceuticals USA, Inc. Have signed an contract with Aventis Pharmaceuticals, Inc.The most typical treatment for hydrocephalus may be the medical implantation of a shunt or valve, a flexible tube placed into the mind to divert excess CSF from the relative head to the abdomen. Codman Neuro has been advancing the care of hydrocephalus sufferers for nearly 17 years.

PRESS RELEASE CAMBRIDGE, Mass.—-Biogen announced today the appointment of Matt Griffiths as senior vice president and chief information officer . He’ll report to the firm’s executive vice president of Business and Technology Solutions, Adriana Karaboutis. Mr. Griffiths was promoted to the CIO part from his placement as vice president of Pharmaceutical Procedures and Corporate IT, having became a member of Biogen from Dell previous this full year. Mr. Griffiths shall develop Biogen’s overall technique for enterprise it , including business engagement, global solution advancement and support, and infrastructure, even though also supporting the organization’s primary business and developing pipeline.